PWPCM
CELG

Perella Weinberg Partners Capital Management’s Celgene Corp CELG Stock Holding History

Perella Weinberg Partners Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-239,600
Closed -$14M – 316
2013
Q2 		$14M Buy
+239,600
New +$14.4M 0.95% 30

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Perella Weinberg Partners Capital Management's CELG Position: Q3 2019 in Review

Perella Weinberg Partners Capital Management sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 373,965 shares — an estimated $34.6M sold.

Perella Weinberg Partners Capital Management first reported a position in CELG in Q2 2013 and held it in 3 quarters. The position peaked at $34.6M in Q2 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Perella Weinberg Partners Capital Management reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Perella Weinberg Partners Capital Management sold 373,965 Celgene Corp shares in Q3 2019, an estimated $34.6M.
  • Perella Weinberg Partners Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 3 quarters.
  • Perella Weinberg Partners Capital Management's Celgene Corp position peaked at $34.6M in Q2 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Perella Weinberg Partners Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.